scispace - formally typeset
K

Kate L. Jeffrey

Researcher at Harvard University

Publications -  34
Citations -  4494

Kate L. Jeffrey is an academic researcher from Harvard University. The author has contributed to research in topics: Epigenetics & Innate immune system. The author has an hindex of 16, co-authored 28 publications receiving 3625 citations. Previous affiliations of Kate L. Jeffrey include Rockefeller University & Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses

TL;DR: It is shown that the activation of the microtubule-associated guanine nucleotide exchange factor GEF-H1, encoded by Arhgef2, is essential for sensing of foreign RNA by RIG-I–like receptors.
Journal ArticleDOI

HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus

TL;DR: Overall, these findings reveal that IFN antiviral response is mediated by HELZ2 transcriptional upregulation, enrichment of Helicase With Zinc Finger 2 protein levels in the nucleus, and activation of a transcriptional program that appears to modulate intracellular lipid state.
Journal ArticleDOI

A Requirement for Argonaute 4 in Mammalian Antiviral Defense

TL;DR: AGO-loaded virus-derived short interfering RNAs (vsiRNAs), a molecular marker of antiviral RNAi, are identified in macrophages infected with influenza or influenza lacking the IFN and RNAi suppressor NS1, which are uniquely diminished without AGO4.
Journal ArticleDOI

Epigenome-metabolome-microbiome axis in health and IBD.

TL;DR: Evidence that the host epigenome plays a significant role in orchestrating the bidirectional crosstalk between mammals and their commensal microorganisms is reviewed and emerging insights into the intricate connection between the microbiome and epigenetic enzyme activity via host or bacterial metabolites are presented.